雷帕霉素对肾小管上皮细胞增殖和凋亡的影响

雷帕霉素对肾小管上皮细胞增殖和凋亡的影响

成芳,赵冰封

安徽医科大学第二附属医院,安徽省妇幼保健院

收稿日期:2017-06-01 修回日期:2017-06-10 出版日期:2017-08-25 发布日期:2017-08-25

The effect of rapamycin in the renal tubular epithelial cell proliferation and apoptosis

The Second Hospital of Anhui Medical University,

Received:2017-06-01 Revised:2017-06-10 Online:2017-08-25 Published:2017-08-25

摘要/Abstract

摘要： 目的探讨雷帕霉素对肾小管上皮细胞增殖和凋亡的影响。方法体外培养肾小管上皮细胞(HK-2细胞),选择100, 200, 400, 800 ng/ml雷帕霉素作用于HK-2细胞24、48、72h。利用 MTT实验分析雷帕霉素对HK-2细胞增殖的影响,并计算各浓度及不同时间的增殖抑制率优化雷帕霉素作用的浓度和时间；选择最佳的作用浓度和作用时间处理HK-2细胞,通过流式细胞分析技术,分析雷帕霉素对HK-2细胞的凋亡的影响。结果 MTT实验显示不同浓度的雷帕霉素,对增殖有抑制作用,且表现浓度依赖性和时间依赖性；RAPA可以促进HK-2细胞的凋亡。结论通过HK-2细胞模型研究,发现雷帕霉素可抑制肾小管上皮细胞增殖、促进细胞凋亡。

Abstract: Objective To investigate the effect of rapamycin on the human renal tubular epithelial cell proliferation and apoptosis. Methods HK-2 cells were cultured in vitro, and treated with 100, 200, 400 and 800 ng/ml rapamycin for 24, 48 and 72 hours. MTT assay was used to detect the inhibition effects on HK-2 cells proliferation; and the flow cytometry was performed to study the effects on the HK-2 cells apoptosis. Results MTT results showed that rapamycin has inhibitory effect on the HK-2 cells proliferation depending on the concentration and time; Flow cytometry indicated that rapamycin could promote the HK-2 cells apoptosis. Conclusion The cell model shows that rapamycin inhibits the renal tubular epithelial cells proliferation and promotes the renal tubular epithelial cells apoptosis.

成芳,赵冰封. 雷帕霉素对肾小管上皮细胞增殖和凋亡的影响[J]. .

参考文献

[1] Lim W H, Eris J, Kanellis J, et al. A systematic review of conversion from calcineurin inhibitor to mammalian target of rapamycin inhibitors for maintenance immunosuppression in kidney transplant recipients[J]. Am J Transplant, 2014,14(9):2106-2119.
[2] Gallon L, Traitanon O, Yu Y, et al. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells[J]. Transplantation, 2015,99(9):1774-1784.
[3] Mori H, Inoki K, Masutani K, et al. The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential[J]. Biochem Biophys Res Commun, 2009,384(4):471-475.
[4] 王德光,李学旺等. 小剂量雷帕霉素延缓小鼠糖尿病肾病进展的研究.中国糖尿病杂志,18(7):110-114,2010.
[5] Lu M K, Gong X G, Guan K L. mTOR in podocyte function: is rapamycin good for diabetic nephropathy?[J]. Cell Cycle, 2011,10(20):3415-3416.
[6] Teng B, Duong M, Tossidou I, et al. Role of protein kinase C in podocytes and development of glomerular damage in diabetic nephropathy[J]. Front Endocrinol (Lausanne), 2014,5:179.
[7] Huang J S, Lee Y H, Chuang L Y, et al. Cinnamaldehyde and nitric oxide attenuate advanced glycation end products-induced the Jak/STAT signaling in human renal tubular cells[J]. J Cell Biochem, 2015,116(6):1028-1038.
[8] 校丽芳, 严玉澄. 雷帕霉素及其相关分子靶点在糖尿病肾病发病机制中的研究进展[J]. 上海医学, 2009(03):260-262.
[9] Hay N, Sonenberg N. Upstream and downstream of mTOR [J]. Genes Dev, 2004,18(16):1926-1945.
[10] Fingar DC, Blenis J. The Target of Rapamycin (TOR): An integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression.Oncogene. 2004,23(18) 3151.
[11] Jacinto E, Loewith R, Schmidt A, et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive [J]. Nat Cell Biol, 2004,6(11):1122-1128.
[12] Pallet N, Thervet E, Le Corre D, et al. Rapamycin inhibits human renal epithelial cell proliferation: effect on cyclin D3 mRNA expression and stability [J]. Kidney Int, 2005,67(6):2422-2433.